4.4.2025 10:52:15 CEST | Thor Medical ASA | Mandatory notification of trade
primary insiders
Oslo, Norway, 4 April 2025: Scatec Innovation AS, a close associate of board
member of Thor Medical ASA John Andersen, has today acquired 354,453 shares in
Thor Medical ASA from its controlled subsidiary, Scatec Invest IV AS, also a
close associate of John Andersen, with a price of NOK 2.388 per share,
reflecting the last 5 days' vwap for the share. The transaction is an internal
group transaction to settle balances between the parent company and its
subsidiary.
Primary insider notifications pursuant to the market abuse regulation article 19
are attached.
This information is subject to disclosure requirements pursuant to the EU Market
Abuse Regulation article 5 and the Norwegian Securities Trading Act section
5-12.
Contacts
Gisle Bjørnstad, CFO, Scatec Innovation AS, +47 95142892,
gisle.bjornstad@scatec.no
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.no - http://www.thormedical.no.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18484477/5914/Download%20announce
ment%20as%20PDF.pdf
20250404 - Primary insider notification - Scatec Invest IV AS and Scatec
Innovation AS.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18484477/5913/20250404%20-%20Prim
ary%20insider%20notification%20-%20Scatec%20Invest%20IV%20AS%20and%20Scatec%20In
novation%20AS.pdf